Back
Voyager Therapeutics Vs. United States Cellular Industry Stock Comparison
Buy
53
VYGR
Voyager Therapeutics
Last Price:
8.46
Seasonality Move:
-6.11%
Buy
71
USM
United States Cellular
Last Price:
44.52
Seasonality Move:
5.31%
Buy
53
Voyager Therapeutics (VYGR)
is a Buy
Is Voyager Therapeutics a Buy, Sell or Hold?
- The current Voyager Therapeutics [VYGR] share price is $8.43. The Score for VYGR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- VYGR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
United States Cellular (USM)
is a Buy
Is United States Cellular a Buy, Sell or Hold?
- The current United States Cellular [USM] share price is $45.10. The Score for USM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- USM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VYGR Stock Price Chart
What is Voyager Therapeutics's stock price today?
-
The Voyager Therapeutics share price today is $8.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYGR is experiencing slight selling pressure.
USM Stock Price Chart
What is United States Cellular's stock price today?
-
The United States Cellular share price today is $45.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and USM is experiencing buying pressure, which is a positive indicator for future bullish movement.
VYGR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 49.52 | Sell |
| Chaikin Money Flow: | -264977 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.67 - 8.63) | Buy |
| Bollinger Bands (100): | (7.58 - 9.34) | Sell |
USM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 67.73 | Buy |
| Chaikin Money Flow: | 133355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.95 - 42.71) | Buy |
| Bollinger Bands (100): | (34.57 - 42.69) | Buy |
VYGR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.51 | Sell |
| 20-day SMA: | 8.24 | Buy |
| 50-day SMA: | 8.75 | Sell |
| 200-day SMA: | 8.16 | Buy |
| 8-day EMA: | 8.5 | Sell |
| 20-day EMA: | 8.44 | Sell |
| 50-day EMA: | 8.48 | Sell |
| 200-day EMA: | 8.34 | Buy |
USM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.04 | Buy |
| 20-day SMA: | 39.26 | Buy |
| 50-day SMA: | 37.06 | Buy |
| 200-day SMA: | 40.1 | Buy |
| 8-day EMA: | 43.38 | Buy |
| 20-day EMA: | 40.49 | Buy |
| 50-day EMA: | 38.49 | Buy |
| 200-day EMA: | 36.73 | Buy |
Voyager Therapeutics Earnings Growth & VYGR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.13 per share, a decrease this year of $3.04 per share, and a decrease next year of $0.08 per share.
United States Cellular Earnings Growth & USM Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.75 per share, and a decrease next year of $3.46 per share.
Voyager Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United States Cellular Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||